American entrepreneur and convicted securities fraudster who became notorious in 2015 for raising the price of the antiparasitic drug Daraprim from $13.50 to $750 per pill as CEO of Turing Pharmaceuticals — becoming the public face of pharmaceutical price gouging — and who was subsequently convicted of securities fraud.
Became the defining symbol of pharmaceutical price exploitation — Shkreli's Daraprim price increase triggered a national debate about drug pricing, congressional hearings, and public outrage that shaped the political landscape around pharmaceutical regulation for years.
No recorded historical influences.
Discussing
Ask anything about Martin Shkreli — their ideas, influences, contradictions, legacy.
Sign in to start a conversation.